BPTH Chart
See on advanced chart >
About
Bio-path Holdings, Inc. is a development stage company with its lead cancer drug candidate, Liposomal Grb-2 , currently in clinical trials. The Company was founded with technology from The University of Texas, MD Anderson Cancer Center and is dedicated to...
Read More
- HighlightA biotechnology company that develops a portfolio of targeted nucleic acid cancer drugs
- ExchangeNASDAQ
- Listing Date03/10/2014
- Established Date05/10/2007
- Full-time Employees10
- Address4710 Bellaire Boulevard Suite 210 Bellaire Texas 77401
- Tel1-832-7421357
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals